Maze Therapeutics, Inc. · NASDAQ:MAZE

Coloma Jason V sold 27,858 Maze Therapeutics, Inc. shares (Form 4)

Traded Jun 22 to Jun 23, 2026 · Filed Jun 24, 2026

From Jun 22 to Jun 23, 2026, Coloma Jason V (Director, Chief Executive Officer) sold 27,858 Maze Therapeutics, Inc. shares at an average US$26.04 for US$726K under a trading plan, leaving 319,079 shares. Filed Jun 24, 2026 (Form 4).

Sold
27,858 shares
Price
US$26.04 average (US$26.00 to US$26.05)
Value
US$726K
Holding after
319,079 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 22, 2026Common StockSale1,953US$26.00342,944Indirect
Jun 22, 2026Common StockSale2,040US$26.0025,930Indirect
Jun 23, 2026Common StockSale23,865US$26.05319,079Indirect

Source

View original at SEC

Related